Can Certain Genotypes Predispose to Poor Asthma Control in Children? A Pharmacogenetic Study of 9 Candidate Genes in Children with Difficult Asthma
Open Access
- 3 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e60592
Abstract
Objective We tested the hypothesis that patients with difficult asthma have an increased frequency of certain genotypes that predispose them to asthma exacerbations and poor asthma control. Methods A total of 180 Caucasian children with confirmed asthma diagnosis were selected from two phenotypic groups; difficult (n = 112) versus mild/moderate asthma (n = 68) groups. All patients were screened for 19 polymorphisms in 9 candidate genes to evaluate their association with difficult asthma. Key Results The results indicated that LTA4H A-9188>G, TNFα G-308>A and IL-4Rα A1727>G polymorphisms were significantly associated with the development of difficult asthma in paediatric patients (pC, IL-4Rα T1570>C and IL-4Rα A1727>G and CA haplotype of TNFα C-863>A and TNFα G-308>A polymorphisms) which were significantly associated with difficult asthma in children (p = 0.04 and p = 0.018, respectively). Conclusions and Clinical Relevance The study revealed multiple SNPs and haplotypes in LTA4H, TNFα and IL4-Rα genes which constitute risk factors for the development of difficult asthma in children. Of particular interest is the LTA4H A-9188>G polymorphism which has been reported, for the first time, to have strong association with severe asthma in children. Our results suggest that screening for patients with this genetic marker could help characterise the heterogeneity of responses to leukotriene-modifying medications and, hence, facilitate targeting these therapies to the subset of patients who are most likely to gain benefit.Keywords
This publication has 49 references indexed in Scilit:
- Tumour Necrosis Factor Gene Polymorphism and Disease PrevalenceScandinavian Journal of Immunology, 2011
- The pharmacogenetics and pharmacogenomics of asthma therapyThe Pharmacogenomics Journal, 2011
- Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype DataHuman Heredity, 2008
- Arginine-16 2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterolThorax, 2006
- Overview of the pharmacogenetics of asthma treatmentThe Pharmacogenomics Journal, 2006
- Tumour necrosis factor gene polymorphisms and childhood wheezingEuropean Respiratory Journal, 2005
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialThe Lancet, 2004
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthmaThorax, 2003
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997